Antibodies to cytokine receptor zalpha11
    93.
    发明授权
    Antibodies to cytokine receptor zalpha11 有权
    细胞因子受体zalpha11的抗体

    公开(公告)号:US07638286B2

    公开(公告)日:2009-12-29

    申请号:US11537835

    申请日:2006-10-02

    IPC分类号: G01N33/53 C07K16/00

    摘要: Novel polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed for zalpha11, a novel cytokine receptor. The polypeptides may be used within methods for detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo. Ligand-binding receptor polypeptides can also be used to block ligand activity in vitro and in vivo. The polynucleotides encoding zalpha11, are located on chromosome 16, and can be used to identify a region of the genome associated with human disease states. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.

    摘要翻译: 公开了新型多肽,编码多肽的多核苷酸,以及相关的组合物和方法,用于zalpha11,一种新的细胞因子受体。 多肽可用于检测在体外和体内刺激造血,淋巴和骨髓细胞增殖和/或发育的配体的方法。 配体结合受体多肽也可用于在体外和体内阻断配体活性。 编码zalpha11的多核苷酸位于染色体16上,可用于鉴定与人类疾病状态相关的基因组区域。 本发明还包括生产蛋白质的方法,用途及其抗体。

    Method for detecting activated CD3+ T-cells
    97.
    发明授权
    Method for detecting activated CD3+ T-cells 失效
    检测激活的CD3 + T细胞的方法

    公开(公告)号:US07563568B2

    公开(公告)日:2009-07-21

    申请号:US10806294

    申请日:2004-03-22

    IPC分类号: C12Q1/68

    摘要: The present invention relates to ZCYTO18 polynucleotide and polypeptide molecules. The ZCYTO18 is a novel cytokine. The polypeptides may be used within methods for stimulating the proliferation and/or development of hematopoietic cells in vitro and in vivo. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.

    摘要翻译: 本发明涉及ZCYTO18多核苷酸和多肽分子。 ZCYTO18是一种新型细胞因子。 多肽可用于在体外和体内刺激造血细胞的增殖和/或发育的方法中。 本发明还包括生产蛋白质的方法,用途及其抗体。

    Protease-activated receptor PAR4 (ZCHEMR2)

    公开(公告)号:US07122342B1

    公开(公告)日:2006-10-17

    申请号:US09371333

    申请日:1999-08-10

    IPC分类号: C12N15/12

    CPC分类号: C07K14/705

    摘要: The present invention relates to polynucleotide and polypeptide molecules for PAR4, a novel member of the protease-activated receptor family. The polypeptides, and polynucleotides encoding them, mediate biological responses and/or cellular signaling in response to proteases. Protease cleavage of PAR4 exposes a PAR4 extracellular amino terminal portion that serves as a ligand for the PAR4 receptor. PAR4 may be used as a target in drug screening, and further used to identify proteinaceous or non-proteinaceous PAR4 agonists and antagonists. The present invention also includes antibodies to the PAR4 polypeptides.

    Murine interferon-α
    100.
    发明授权
    Murine interferon-α 有权
    鼠干扰素α

    公开(公告)号:US06902729B2

    公开(公告)日:2005-06-07

    申请号:US10358619

    申请日:2003-02-04

    摘要: Interferons represent an important class of biopharmaceutical products, which have a proven track record in the treatment of a variety of medical conditions, including the treatment of certain autoimmune diseases, the treatment of particular cancers, and the enhancement of the immune response against infectious agents. The present invention provides a new form of murine interferon-α, which has applications in diagnosis and therapy.

    摘要翻译: 干扰素代表了一类重要的生物制药产品,在治疗各种医疗条件方面具有良好的记录,包括治疗某些自身免疫性疾病,治疗特定癌症,以及增强针对感染因子的免疫应答。 本发明提供了一种新型的鼠干扰素-α,其在诊断和治疗中具有应用。